Found: 32
Select item for more details and to access through your institution.
Dendritic Cell-Based Vaccines in Patients with Hematological Malignancies.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 938, n. 1, p. 359, doi. 10.1111/j.1749-6632.2001.tb03603.x
- By:
- Publication type:
- Article
Expression of Novel Surface Antigens on Early Hematopoietic Cells<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1999, v. 872, n. 1, p. 25, doi. 10.1111/j.1749-6632.1999.tb08450.x
- By:
- Publication type:
- Article
Characterization of Purified and Ex Vivo Manipulated Human Hematopoietic Progenitor and Stem Cells in Xenograft Recipients.
- Published in:
- Annals of the New York Academy of Sciences, 1999, v. 872, n. 1, p. 200, doi. 10.1111/j.1749-6632.1999.tb08465.x
- By:
- Publication type:
- Article
Regulation of Transendothelial Migration of Hematopoietic Progenitor Cells.
- Published in:
- Annals of the New York Academy of Sciences, 1999, v. 872, n. 1, p. 176, doi. 10.1111/j.1749-6632.1999.tb08463.x
- By:
- Publication type:
- Article
Welche Chancen bietet die Immunonkologie für ein indikationsübergreifendes Langzeitüberleben?
- Published in:
- Oncology Research & Treatment, 2015, v. 38, p. 6, doi. 10.1159/000381363
- By:
- Publication type:
- Article
Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 529, doi. 10.1111/ejh.13690
- By:
- Publication type:
- Article
Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 3, p. 255, doi. 10.1111/ejh.13281
- By:
- Publication type:
- Article
Increased incidence of IgA antibodies to the epstein-barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
- Published in:
- International Journal of Cancer, 1986, v. 38, n. 1, p. 55, doi. 10.1002/ijc.2910380110
- By:
- Publication type:
- Article
ABCL-021: FRONT-MIND: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy and Safety of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP Alone for Newly-Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S376, doi. 10.1016/S2152-2650(21)01860-7
- By:
- Publication type:
- Article
Poster: ABCL-021: FRONT-MIND: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy and Safety of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP Alone for Newly-Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01533-0
- By:
- Publication type:
- Article
Intradermal Vaccinations With RNA Coding for TAA Generate CD8<sup>+</sup> and CD4<sup>+</sup> Immune Responses and Induce Clinical Benefit in Vaccinated Patients.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 5, p. 990, doi. 10.1038/mt.2010.289
- By:
- Publication type:
- Article
Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2000, v. 110, n. 3, p. 563, doi. 10.1046/j.1365-2141.2000.02157.x
- By:
- Publication type:
- Article
Bendamustine in Indolent Non-Hodgkin's Lymphoma A Practice Guide for Patient Management.
- Published in:
- Oncologist, 2013, v. 18, n. 8, p. 954, doi. 10.1634/theoncologist.2013-0079
- By:
- Publication type:
- Article
Severe idiopathic erythroblastic synartesis: successful treatment with the anti-CD20 monoclonal antibody rituximab.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 6, p. 547, doi. 10.1111/j.1600-0609.2010.01420.x
- By:
- Publication type:
- Article
A phase 2a, single‐arm, open‐label study of tafasitamab, a humanized, Fc‐modified, anti‐CD19 antibody, in patients with relapsed/refractory B‐precursor cell acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 22, p. 4190, doi. 10.1002/cncr.33796
- By:
- Publication type:
- Article
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2<sup>nd</sup>-line therapy for relapsed and refractory multiple myeloma - a phase II trial.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 770, doi. 10.1111/bjh.14481
- By:
- Publication type:
- Article
THE CLINICAL ROLE OF HEMATOPOIETIC GROWTH FACTORS IN PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANTATION.
- Published in:
- Vox Sanguinis, 1994, v. 67, p. 43, doi. 10.1111/j.1423-0410.1994.tb04542.x
- By:
- Publication type:
- Article
Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 12, p. 1921, doi. 10.1007/s00432-010-0851-6
- By:
- Publication type:
- Article
Generation of antigen-presenting cells for soluble protein antigens ex vivo from peripheral blood CD34.
- Published in:
- European Journal of Immunology, 1996, v. 26, n. 3, p. 595, doi. 10.1002/eji.1830260314
- By:
- Publication type:
- Article
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.
- Published in:
- Nature Medicine, 2012, v. 18, n. 8, p. 1254, doi. 10.1038/nm.2883
- By:
- Publication type:
- Article
The fascinating life of hematopoietic stem cells.
- Published in:
- Nature Medicine, 1998, v. 4, n. 10, p. 1118, doi. 10.1038/2611
- By:
- Publication type:
- Article
Phase I study of orally administered <sup>14</sup>Carbon-isotope labelled-vistusertib (AZD2014), a dual TORC1/2 kinase inhibitor, to assess the absorption, metabolism, excretion, and pharmacokinetics in patients with advanced solid malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Molecular Marker Analyses From the SATURN Trial.
- Published in:
- Clinical Advances in Hematology & Oncology, 2012, v. 10, n. 1, p. 33
- By:
- Publication type:
- Article
CLONAL SELECTION OF CD20-NEGATIVE NON-HODGKIN'S LYMPHOMA CELLS AFTER TREATMENT WITH ANTI-CD20 ANTIBODY RITUXIMAB.
- Published in:
- British Journal of Haematology, 1999, v. 106, n. 2, p. 571, doi. 10.1046/j.1365-2141.1999.01608.x
- By:
- Publication type:
- Article
Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin.
- Published in:
- British Journal of Haematology, 1993, v. 84, n. 3, p. 402, doi. 10.1111/j.1365-2141.1993.tb03093.x
- By:
- Publication type:
- Article
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Late-onset hemophagocytic lymphohistiocytosis (HLH) in an adult female with Griscelli syndrome type 2 (GS2)
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Late-onset hemophagocytic lymphohistiocytosis (HLH) in an adult female with Griscelli syndrome type 2 (GS2).
- Published in:
- 2015
- By:
- Publication type:
- Letter
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article